ID: ALA3245219

Max Phase: Preclinical

Molecular Formula: C28H35N3O9S

Molecular Weight: 397.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(Sc2c(OC)cc(NC(C)CCCN)c3ncccc23)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O

Standard InChI:  InChI=1S/C22H27N3O2S.C6H8O7/c1-15(6-4-12-23)25-19-14-20(27-3)22(18-7-5-13-24-21(18)19)28-17-10-8-16(26-2)9-11-17;7-3(8)1-6(13,5(11)12)2-4(9)10/h5,7-11,13-15,25H,4,6,12,23H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

Standard InChI Key:  JDQIZIHTAJGKLJ-UHFFFAOYSA-N

Associated Targets(non-human)

Rhesus monkey 3147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasmodium cynomolgi 553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 397.54Molecular Weight (Monoisotopic): 397.1824AlogP: 4.94#Rotatable Bonds: 9
Polar Surface Area: 69.40Molecular Species: BASEHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.20CX LogP: 3.67CX LogD: 1.07
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -0.52

References

1. Tanabe K, Chen EH, Verma BL, Saggiomo AJ, Nodiff EA..  (1978)  Modifications of primiaquine as antimalarials. 2. 5-Phenylthio and 5-anilino derivatives of primaquine.,  21  (1): [PMID:412967] [10.1021/jm00199a028]

Source